Peripheral Neuropathy Trial, Recruiting (NCT07583823)

Peripheral Neuropathy Trial, Recruiting NCT07583823 Sponsor: University of Minnesota Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07583823 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with cardiac amyloidosis (a condition where a protein called amyloid builds up in the heart) according to recognised medical guidelines
You have a pacemaker implanted in your heart (with or without a defibrillator)
Your pacemaker is set to a specific mode that matches your heart rhythm (your doctor can confirm if your device settings qualify)
Your heart's main pumping chamber (left ventricle) is not enlarged, as confirmed by an ultrasound of the heart
You are able to read and sign a consent form agreeing to take part
You are able to speak and understand English

Who may not be able to join:

Your pacemaker produces a heartbeat signal that is too wide (over 150 milliseconds) on a heart tracing (ECG), which may suggest the pacemaker is causing the heart to beat in an uncoordinated way
Your heart's main pumping chamber (left ventricle) is enlarged

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Valmiki Maharaj, University of Minnesota

Phone: 612-626-5863

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07583823

Sponsor: University of Minnesota

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 612-626-5863

More information: https://clinicaltrials.gov/study/NCT07583823

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with cardiac amyloidosis (a condition where a protein called amyloid builds up in the heart) according to recognised medical guidelines
You have a pacemaker implanted in your heart (with or without a defibrillator)
Your pacemaker is set to a specific mode that matches your heart rhythm (your doctor can confirm if your device settings qualify)
Your heart's main pumping chamber (left ventricle) is not enlarged, as confirmed by an ultrasound of the heart
You are able to read and sign a consent form agreeing to take part
You are able to speak and understand English

Who may not be able to join:

Your pacemaker produces a heartbeat signal that is too wide (over 150 milliseconds) on a heart tracing (ECG), which may suggest the pacemaker is causing the heart to beat in an uncoordinated way
Your heart's main pumping chamber (left ventricle) is enlarged

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Minnesota

Registry

ClinicalTrials.gov

Start date

10 October 2025

Est. completion

10 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Kansas City Cardiomyopathy Questionnaire Score; Composite of any cardiovascular event

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov